PerkinElmer

Project Farma is a consulting firm that provides specialized services to healthcare companies within the pharmaceutical and medical device sectors. The firm focuses on biomanufacturing strategy and execution, assisting clients with capital projects, technology transfers, facility construction, and strategy development. Additionally, Project Farma offers expertise in validation processes and ensures compliance with regulatory standards. By addressing the complete supply chain, the firm aims to enhance operational efficiency and support the successful development and production of healthcare products.

Covaris specializes in the development, manufacturing, and marketing of tools for pre-analytical sample preparation used in genomic and proteomic analysis. The company provides a range of products, including instruments, kits, tubes, vials, reagents, and accessories. By offering these technologies, Covaris aims to facilitate research and life science innovations, enabling clients to make scientific discoveries, develop new assays, and enhance bioanalytical outcomes.

Virtue Diagnostics (Suzhou) Co., Ltd. is an in vitro diagnostic company established in 2019 and headquartered in Suzhou, China, with a research and development office in Singapore. The company specializes in developing advanced diagnostic technologies aimed at infectious diseases, cancer, and chronic diseases. Its offerings include clinical mass spectrometry, multiplex immunohistochemistry for pathology-based cancer detection, and a molecular and immunoassay platform. Through these technologies, Virtue Diagnostics aims to enhance disease detection and management, contributing to improved healthcare outcomes.

BioLegend is a biotechnology company based in San Diego, California, specializing in the development of immunological reagents for biomedical research. The firm produces a wide range of high-quality antibodies, recombinant proteins, bioassays, and other research reagents. Its offerings include tools for flow cytometry, cell biology, and functional assays, which support research in various fields such as immunology, cancer, and stem cell development. By providing these advanced products, BioLegend aims to enhance the capabilities of scientists and accelerate discoveries in biomedical research.

Sirion Biotech specializes in viral vector technology, which is essential for delivering genetic material into cells and developing innovative therapeutics, such as gene therapy for cancer. Founded in 2007, the company has become a global leader in gene modification of mammalian cells, offering a range of viral vector types, including adenovirus, adeno-associated virus (AAV), and lentivirus, all available within weeks. Sirion Biotech supports both academic and industry sectors through various commercial arrangements, including fee-for-service and licensing agreements. The company has experienced significant growth, with an annual increase of 70% since its inception, and has successfully completed over 500 projects. With offices in Munich, Tokyo, New Hampshire, and Tel Aviv, Sirion Biotech is well-positioned to meet the needs of researchers and developers in the field of gene therapy. The company is privately held and actively seeks new investors to support its ongoing growth and technological advancements in the rapidly evolving biotechnology industry.

Immunodiagnostic Systems Holdings is a specialized company engaged in the development, manufacturing, and marketing of in-vitro diagnostic tests for clinical laboratories. Based in Boldon, United Kingdom, the company primarily serves markets in the UK, US, Germany, and France, among others. Its key offerings include a range of immunoassays and automated immunoanalyser technologies, notably the IDS-iSYS system, which utilizes chemiluminescence and absorbency technology for efficient and reliable immunoassay testing. The company focuses on various clinical areas, including bone and calcium metabolism, growth, hypertension, chronic kidney disease, autoimmunity, and infectious diseases. Established in 1977, Immunodiagnostic Systems Holdings aims to enhance diagnostic outcomes for patients through innovative automated and manual assays, ensuring both testing efficiency and quality in specialty immunoassay applications.

Nexcelom Bioscience LLC is a biotechnology company specializing in the development and marketing of image cytometry products focused on cell analysis for life science and biomedical research. Established in 2003 and based in Lawrence, Massachusetts, Nexcelom offers a range of products including the Cellometer, which uses bright field and fluorescence imaging modes to count and analyze cell lines and primary cells, and the Celigo, a high-throughput image cytometry system designed for both adherent and suspension cells in microwell plates. In addition to these instruments, the company provides fluorescent reagents and kits for cell counting and cell-based assays, catering to various research fields such as immuno-oncology, cell therapy, drug discovery, vaccine development, and therapeutic cell line generation.

Oxford Immunotec is a diagnostics company specializing in the development and commercialization of proprietary tests for immunology and infectious diseases. Headquartered in the UK, with operations in the US, the company's core technology, T-SPOT, measures specific T cell responses to inform diagnosis, prognosis, and monitoring of patients with immune-regulated conditions. Its flagship product, T-SPOT.TB, detects active and latent tuberculosis infection, while T-SPOT.CMV monitors cytomegalovirus in transplant recipients. Oxford Immunotec serves independent laboratories, hospital systems, and public and private institutions worldwide.

Carterra, Inc. specializes in developing and commercializing innovative biomolecular interaction analysis solutions, primarily utilizing label-free technologies. The company offers a range of products, including its MultipleX 96 array-based surface plasmon resonance (SPR) imaging system and the Continuous Flow Microspotter (CFM), which is designed for high-throughput microarray printing. Carterra's services encompass epitope binning and mapping, first-pass kinetics, and assay development, catering to the needs of pharmaceutical and biotechnology clients. Its advanced platforms enable users to conduct kinetic and epitope analysis, supporting the rapid screening of antibodies and identification of potential therapeutic candidates. Founded in 2005 and headquartered in Salt Lake City, Utah, Carterra has additional offices in California, Massachusetts, and Germany, and distributes its products globally, including in China and Japan.

Horizon Discovery Group plc is a UK-based life science company specializing in gene editing and gene modulation technologies that advance research and clinical applications in human health. Established in 2007 and headquartered in Cambridge, the company designs, manufactures, and applies a wide array of gene editing tools, including custom-made and off-the-shelf RNA interference (RNAi) reagents, CRISPR reagents, and various cell models. Horizon Discovery offers services such as pooled and arrayed CRISPR screens, drug screens, and immunology assays, catering to the needs of academic research labs, biopharmaceutical companies, and contract research organizations. Its extensive product catalog includes over 1,000,000 cell and reagent products that help scientists investigate genetic anomalies associated with diseases like cancer. The company has formed strategic partnerships with various institutions to enhance its offerings, including collaborations for developing innovative gene editing technologies. As of December 2020, Horizon operates as a subsidiary of PerkinElmer (UK) Holdings Ltd.

Cisbio Bioassays, a life sciences company, develops various assays and reagents for pharmaceutical, biotechnology, academia, and contract research organizations worldwide. It offers G-protein coupled receptor (GPCR), a homogeneous time-resolved fluorescence (HTRF) cellular platform solution; kinases and cell signaling solutions, such as assays for covering various needs for monitoring kinase targets; and a line of HTRF epigenetic toolbox reagents and kits for high throughput screening and investigation of epigenetic targets.

SSI is one of the manufacturers of analytical instruments in China. SSI delivers analytical solutions and services to a wide range of research, academic, government, pharmaceutical, industrial, life sciences and chemical analysis laboratories. Its portfolio includes photoelectric colorimeters, UV-Vis spectrophotometers, atomic absorption spectrophotometers and accessories.

RHS Limited is a biotechnology company based in Thebarton, Australia, that specializes in developing and marketing genetic screening solutions. Founded in 1980, the company offers a range of products, including EmbryoCellect, a preimplantation genetic screening solution, and DOPlify, a whole genome amplification kit. Additionally, RHS provides PG-Seq, a next-generation sequencing workflow for preimplantation genetic testing, as well as related services in preimplantation genetic screening and whole genome amplification. The company focuses on leveraging single-cell genomics technology to detect chromosomal abnormalities in fetal DNA, thereby assisting medical professionals in improving health outcomes through genetic testing. In June 2017, RHS Limited changed its name from Reproductive Health Science Limited and has operated as a subsidiary of PerkinElmer, Inc. since June 2018.

EUROIMMUN AG develops and manufactures medical laboratory reagents for the diagnosis of autoimmune and infectious diseases and allergies. It offers indications for autoimmunity, infections, allergology, antigen detection, and molecular diagnostics; autoimmunity products for rheumatology, hepatology, gastroenterology, endocrinology, neurology, nephrology, dermatology, and infertility; and infection products for immunity determination, CSF diagnostics, emerging viruses, avidity, BIOCHIP Mosaics for infectious serology, and others, as well as additional reagents for determination of acute infections.

Tulip Diagnostics is a company that specializes in the manufacturing of in-vitro diagnostic reagents, kits, and instruments. It focuses on the research, development, and design of systems and platforms for diagnostic applications. The company is dedicated to creating indigenous semi-automated and automated analyzers, enhancing the capabilities of diagnostic testing. With a commitment to innovation in the field of diagnostics, Tulip Diagnostics aims to provide high-quality solutions that meet the evolving needs of healthcare providers.

Vanadis Diagnostics, AB is a Swedish company focused on developing non-invasive prenatal testing (NIPT) solutions utilizing digital analysis of cell-free DNA. The company's primary product, Vanadis Smart NIPT, aims to simplify the screening process for trisomies 21, 18, and 13 by removing the complexities associated with traditional DNA amplification and analysis methods. This innovative platform allows healthcare providers to offer reliable and accurate screenings to pregnant women, enhancing access to vital prenatal information. Operating from Sollentuna, Sweden, Vanadis Diagnostics functions as a subsidiary of Perten Instruments AB.

Ceiba Solutions develops informatics platforms and offers managed services to life sciences and health care industries.

Shanghai Haoyuan Biotech Co., Ltd. specializes in the research and development of diagnostic technologies aimed at detecting infectious diseases. The company provides molecular infectious disease screening solutions tailored for blood banks and clinical laboratories across China. By incorporating advanced nucleic acid detection technology, Haoyuan enhances the capabilities of healthcare facilities in identifying various infectious diseases. Additionally, the company has expanded its offerings by including four infectious disease assays that have received approval from China's State Food and Drug Administration, thereby reinforcing its commitment to improving public health through innovative diagnostic tools.

Caliper Life Sciences, Inc. is a provider of products and services tailored for pharmaceutical and biotechnology companies, as well as government and nonprofit research institutions. The company specializes in integrated systems that encompass instruments, software, reagents, and laboratory automation tools, aimed at enhancing the drug discovery and development process. Its offerings include advanced technologies for molecular imaging, microfluidics, and liquid handling, which address critical challenges in research. Notable products include IVIS Imaging Systems for optical molecular imaging, LabChip systems for drug discovery that enhance data accuracy, and automated liquid handling instruments such as the Caliper Sciclone. Additionally, Caliper provides contract research services, transgenic animal services, and comprehensive support for drug discovery. Founded in 1995 and headquartered in Hopkinton, Massachusetts, Caliper Life Sciences sells its products through a dedicated sales force and a network of distributors, helping researchers streamline their workflows and improve the efficiency of preclinical studies.

Dexela develops advanced 3-D breast imaging technology aimed at the early detection of breast cancer. The company offers a range of products, including the DexTop Digital Mammography Workstation, which streamlines screening workflow and performance, and a 3D reconstruction engine available to OEM partners as a software module. Dexela's flat panel CMOS X-ray detectors serve various medical applications, such as mammography, breast CT, dental imaging, and fluoroscopy. Additionally, the company provides consulting services in digital tomosynthesis, mammography acquisition geometry, and the optimal reconstruction of 3D data. Founded in 2003 and headquartered in London, Dexela also operates an X-ray research and development facility in Sudbury, Massachusetts.

Labtronics Inc is a leading provider of data integration solutions tailored for laboratories across various industries. The company specializes in procedures-based Electronic Laboratory Notebook (ELN) services, notably through its Nexxis ELNTM, designed for quality control applications. In addition to ELN services, Labtronics offers the Nexxis iLABTM laboratory automation platform, which enhances workflow efficiency and instrument integration. By focusing on innovative solutions that address the specific needs of laboratories, Labtronics aims to streamline laboratory processes and improve data management for its clients.

Geospiza Inc. specializes in developing software systems tailored for workflow management in genetic analysis. The company offers two primary products: GeneSifter Analysis Edition, a cloud-based data analysis tool for microarray and sequencing data, and GeneSifter Lab Edition, which supports various laboratory workflows. Geospiza serves a diverse clientele that includes biotechnology and pharmaceutical companies, universities, researchers, contract core facilities, and diagnostic laboratories engaged in genetic testing and the production of biotherapeutics. Founded in 1997 and headquartered in Seattle, Washington, Geospiza focuses on enhancing the efficiency and effectiveness of genetic research and testing processes.

ArtusLabs specializes in developing scientific data management software aimed at enhancing collaboration among researchers and accelerating drug discovery. The company's flagship product, Ensemble for Life Science, is an on-demand software platform that integrates social networking and refined scientific data mining to improve communication and management in research settings. ArtusLabs also offers the Ensemble Electronic Lab Notebook, which enables users to capture experimental data and results, supporting the needs of medicinal chemistry, biology, and bio-analytical departments. Additionally, Ensemble Toolkits allow for the integration of various components within the platform. Founded by the team behind Synthematix, ArtusLabs leverages extensive expertise in managing complex scientific data and fosters strong relationships with scientists worldwide to deliver effective collaborative solutions.

CambridgeSoft Corporation specializes in providing software and solutions for the pharmaceutical, biotechnology, and chemical industries. The company develops a range of products, including enterprise solutions, desktop software, scientific databases, and consulting services, aimed at enhancing discovery, collaboration, and knowledge management. Its principal offering, Chem & Bio Office, is widely recognized as a key communication tool for chemists, facilitating the creation and analysis of chemical and biological information. Additionally, the enterprise version, Chem & Bio Office Enterprise, supports research organizations in deploying comprehensive information solutions through various technologies. CambridgeSoft's offerings are utilized not only in industry but also in higher education and government research, making it a significant player in scientific software development.

chemagen is a key player in the field of automated nucleic acid isolation. The purification of DNA, RNA, or viral DNA/RNA is facilitated through chemagen’s proprietary M-PVA Magnetic Bead technology.

VisEn Medical, Inc. specializes in the design, development, and commercialization of fluorescence in vivo imaging technology platforms. The company focuses on its Fluorescence Molecular Tomographic (FMT) imaging systems and various vivo imaging agents that enhance the identification, characterization, and quantification of disease biomarkers and therapeutic efficacy in living organisms. Among its notable products are ReninSense680, an imaging agent used for monitoring hypertension and renal disease biomarkers, and VivoTagR 680 XL, a fluorescent dye suitable for labeling biomolecules in diverse in vitro and in vivo imaging applications. Additionally, VisEn Medical provides advanced fluorescence tomographic imaging systems to support its imaging technology offerings.

Signature Genomic Laboratories, based in Spokane, Washington, specializes in molecular cytogenetic diagnostic services. The company offers a range of diagnostic testing for both pediatric and adult patients, as well as prenatal testing services. Its offerings include fluorescence in situ hybridization (FISH) analysis of clinically relevant genetic loci, interpretation of genome microarrays, and G-banded karyotype analysis. By providing comprehensive genetic testing and analysis, Signature Genomic Laboratories aims to support clinicians in diagnosing genetic conditions and informing patient care.

SYM-BIO Lifescience, a leading provider of diagnostics instruments and related reagents.

Surendra Genetic Labs, Pvt. Ltd. provides testing services for pregnant mothers and newborns. The company operates as laboratory, which focuses on fetal, maternal, and newborn health.

Analytica of Branford, Inc. develops and markets electrospray ion sources for mass spectrometry.

Opto Technology Inc. specializes in the design, development, and manufacturing of optoelectronic products and light-emitting diodes (LEDs). The company produces a variety of LED-related products tailored for diverse applications, including analytical instrumentation, medical and dental lighting, transportation, as well as industrial and architectural uses. Through its innovative solutions, Opto Technology aims to meet the specific needs of various industries by leveraging advanced optoelectronic technology.

rnel Inc., a recognized leader in custom engineered solutions for gas chromatography applications in the petrochemical, food and beverage, and industrial hygiene markets. The acquisitionis an important strategic initiative to expand PerkinElmer's chromatography portfolio and strengthen its application-focused expertise to best serve the biofuels and hydrocarbon processing industries.

LabMetrix Technologies, Inc. provides metrology-based multi-vendor analytical instrument qualification solutions.

Pediatrix's screening reference laboratory and its StepOne® newborn screening product, which is capable of analyzing more than 50 inherited disorders in newborns, to its genetic screening product offerings. The laboratory provides neonatal screening and consultative services to five states and the District of Columbia, as well as to hospitals and medical groups.

ViaCell is a biotechnology company focused on the area of women’s health. The company develops ViaCord, which enables families preserve their baby’s umbilical cord blood at the time of birth for possible future medical use; and ViaCyte, to broaden reproductive choices for women through the cryopreservation of human unfertilized eggs. ViaCell is based in Boston, Massachusetts.

Applied Biosystems is a prominent provider of innovative instruments and reagents designed to enhance academic and clinical research, drug discovery, and development. The company specializes in the development of instrument-based systems, consumables, software, and services focused on the analysis of DNA, RNA, proteins, and small molecules. Additionally, Applied Biosystems offers field applications support services to assist with genetic and protein analysis solutions. Its products are utilized in various sectors, including pathogen detection, environmental analysis, and forensic DNA analysis, contributing significantly to advancements in scientific research and technology.